ArticleMolecular medicine (Cambridge, Mass.)2018

RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1.

Tom Skaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.